Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
Lehe Yang, Feng Zhou, Yan Zhuang, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 3, pp. 645-657
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Advances on Delivery System of Active Ingredients of Dried Toad Skin and Toad Venom
Dan Zhang, Bingtao Zhai, Jing Sun, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7273-7305
Open Access | Times Cited: 2
Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom
Huan Tian, Feng Zhao, Baosen Yue, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3549-3594
Open Access | Times Cited: 2
Coccinic acid exhibits anti-tumor efficacy against NSCLC harboring EGFR L858R/T790M mutation via the EGFR/STAT3 pathway
Peiyuan Sun, Shuanggou Zhang, Yana Qu, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108038-108038
Closed Access | Times Cited: 2
Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
Lehe Yang, Tianru Zhu, Hua Ye, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 801-812
Open Access | Times Cited: 17
Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway
Zijun Qian, Xiaoting Tian, Yayou Miao, et al.
Cellular Signalling (2023) Vol. 109, pp. 110746-110746
Closed Access | Times Cited: 6
Cinobufagin-induced DNA damage response activates G2/M checkpoint and apoptosis to cause selective cytotoxicity in cancer cells
Jiajing Niu, Wang Jia-mei, Qi Zhang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Hypocrellin A exerts antitumor effects by inhibiting the FGFR1 signaling pathway in non-small cell lung cancer
Lehe Yang, Wenjing Zhu, Yulei Yao, et al.
Phytomedicine (2022) Vol. 97, pp. 153924-153924
Open Access | Times Cited: 9
Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
Xiaona Xie, Xueding Cai, Yemeng Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 12
Synthesis and antiproliferative activities of steroidal lactam conjugates bearing a new nitrogen mustard
Eleni Sflakidou, Panagiotis Dalezis, Dimitrios T. Trafalis, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115133-115133
Closed Access | Times Cited: 4
The role of PI3K/AKT signaling pathway in gallbladder carcinoma.
Zeyu Wu, Xiao Yu, Shuijun Zhang, et al.
PubMed (2022) Vol. 14, Iss. 7, pp. 4426-4442
Closed Access | Times Cited: 6
Bufalin inhibits epithelial-mesenchymal transition and increases radiosensitivity of non-small cell lung cancer via inhibition of the Src signaling
Zijian Wang, Fen Liu, Chen Huang, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 1, pp. 123-134
Open Access | Times Cited: 3
Bufalin-loaded vitamin E succinate-grafted chitosan oligosaccharide/RGD-conjugated TPGS mixed micelles inhibit intraperitoneal metastasis of ovarian cancer
Lan Xu, Shuli Ma, Bozhen Fan, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
Sunshun Yan, Chunbo Ma, Zhou Feng, et al.
Journal of Cancer (2023) Vol. 14, Iss. 17, pp. 3309-3320
Open Access | Times Cited: 3
Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma
Luke Nelson, Kyleen E Castro, Binzhi Xu, et al.
Cell Cycle (2022) Vol. 21, Iss. 10, pp. 1103-1119
Open Access | Times Cited: 5
AT7519 against lung cancer via the IL6/STAT3 signaling pathway
Feng Zhou, Fanyun Zhu, Tianru Zhu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 609, pp. 31-38
Closed Access | Times Cited: 5
A Gene Expression Signature to Predict Nucleotide Excision Repair Defects and Novel Therapeutic Approaches
Rongbin Wei, Hui Dai, Jing Zhang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 5008-5008
Open Access | Times Cited: 4
Ameliorative effects of Turbinaria ornata extract on hepatocellular carcinoma induced by diethylnitrosamine in-vivo
Hamada Shoaib, Amr Negm, Amira O. Abd El‐Azim, et al.
Journal of Molecular Histology (2024)
Closed Access
Unraveling the Molecular Mechanisms of SIRT7 in Angiogenesis: Insights from Substrate Clues
Junjie Ma, Liqian Yang, Jiaxing Wu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11578-11578
Open Access
The diagnostic value investigation of programmed cell death genes in heart failure
Qiuyue Chen, Su Tu
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Bufadienolides from Chansu Injection Synergistically Enhances the Antitumor Effect of Erlotinib by Inhibiting the KRAS Pathway in Pancreatic Cancer
Yanli Guo, Yu Jin, Jie Gao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1696-1696
Open Access
Acetyl-cinobufagin Suppresses Triple Negative Breast Cancer Progression by Inhibiting the STAT3 Pathway
Yufeng Qi, Tianru Zhu, Zitian Liu, et al.
Research Square (Research Square) (2021)
Open Access
Previous Page - Page 2

Scroll to top